Common Genetic Variants of Surfactant Protein-D (SP-D) Are Associated with Type 2 Diabetes

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Pueyo, Neus ^a   Ortega, Francisco J ^a   Mercader, Josep M ^b   Moreno Navarrete, José M ^a   Sabater, Monica ^a   Bonàs, Sílvia ^b   Botas, Patricia ^d   Delgado, Elías ^d   Ricart, Wifredo ^a   Martinez Larrad, María T ^e   Serrano Ríos, Manuel ^e   Torrents, David ^b,c   Fernández Real, José M ^a  

^a Instituto de Salud Carlos III   (Spain)

^b BARCELONA SUPERCOMPUTING CENTER   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; SURFACTANT PROTEIN D;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HEMOGLOBIN BLOOD LEVEL; HOMOZYGOTE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SP D GENE;

DATABASES, GENETIC; DIABETES MELLITUS, TYPE 2; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D;

EID: 84875946684     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060468     Document Type: Article

References (43)

1. Hotamisligil GS, (2006) Inflammation and metabolic disorders. Nature 444: 860-867.
2. Fernandez-Real JM, Pickup JC, (2008) Innate immunity, insulin resistance and type 2 diabetes. Trends Endocrinol Metab 19: 10-16.
3. Fernandez-Real JM, Pickup JC, (2012) Innate immunity, insulin resistance and type 2 diabetes. Diabetologia 55: 273-278.
4. Gubern C, Lopez-Bermejo A, Biarnes J, Vendrell J, Ricart W, et al. (2006) Natural antibiotics and insulin sensitivity: the role of bactericidal/permeability-increasing protein. Diabetes 55: 216-224.
5. Lopez-Bermejo A, Chico-Julia B, Castro A, Recasens M, Esteve E, et al. (2007) Alpha defensins 1, 2, and 3: potential roles in dyslipidemia and vascular dysfunction in humans. Arterioscler Thromb Vasc Biol 27: 1166-1171.
6. Moreno-Navarrete JM, Martinez-Barricarte R, Catalan V, Sabater M, Gomez-Ambrosi J, et al. (2010) Complement factor H is expressed in adipose tissue in association with insulin resistance. Diabetes 59: 200-209.
7. Moreno-Navarrete JM, Ortega FJ, Bassols J, Castro A, Ricart W, et al. (2008) Association of circulating lactoferrin concentration and 2 nonsynonymous LTF gene polymorphisms with dyslipidemia in men depends on glucose-tolerance status. Clin Chem 54: 301-309.
8. Sano H, Kuroki Y, (2005) The lung collectins, SP-A and SP-D, modulate pulmonary innate immunity. Mol Immunol 42: 279-287.
9. Crouch EC, (2000) Surfactant protein-D and pulmonary host defense. Respir Res 1: 93-108.
10. Sorensen GL, Hjelmborg JB, Kyvik KO, Fenger M, Hoj A, et al. (2006) Genetic and environmental influences of surfactant protein D serum levels. Am J Physiol Lung Cell Mol Physiol 290: L1010-1017.
11. Leth-Larsen R, Garred P, Jensenius H, Meschi J, Hartshorn K, et al. (2005) A common polymorphism in the SFTPD gene influences assembly, function, and concentration of surfactant protein D. J Immunol. 174: 1532-1538.
12. Foreman MG, Kong X, DeMeo DL, Pillai SG, Hersh CP, et al. (2011) Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 44: 316-322.
13. Barker DJ, Godfrey KM, Fall C, Osmond C, Winter PD, et al. (1991) Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. Bmj 303: 671-675.
14. Engstrom G, Janzon L, (2002) Risk of developing diabetes is inversely related to lung function: a population-based cohort study. Diabet Med 19: 167-170.
15. Ford ES, Mannino DM, (2004) Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Diabetes Care 27: 2966-2970.
16. Reading PC, Allison J, Crouch EC, Anders EM, (1998) Increased susceptibility of diabetic mice to influenza virus infection: compromise of collectin-mediated host defense of the lung by glucose? J Virol 72: 6884-6887.
17. Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB, et al. (2005) Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 28: 1472-1479.
18. Engstrom G, Hedblad B, Nilsson P, Wollmer P, Berglund G, et al. (2003) Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med 253: 574-581.
19. Fernandez-Real JM, Valdes S, Manco M, Chico B, Botas P, et al. (2011) Surfactant protein d, a marker of lung innate immunity, is positively associated with insulin sensitivity. Diabetes Care 33: 847-853.
20. Valdes S, Botas P, Delgado E, Alvarez F, Cadorniga FD, (2007) Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study. Diabetes Care 30: 2258-2263.
21. Mansego ML, Martinez F, Martinez-Larrad MT, Zabena C, Rojo G, et al. (2012) Common variants of the liver fatty acid binding protein gene influence the risk of type 2 diabetes and insulin resistance in Spanish population. PLoS One 7: e31853.
22. Fernandez-Real JM, Mercader JM, Ortega FJ, Moreno-Navarrete JM, Lopez-Romero P, et al. (2011) Transferrin receptor-1 gene polymorphisms are associated with type 2 diabetes. Eur J Clin Invest 40: 600-607.
23. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, et al. (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40: 638-645.
24. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42: 105-116.
25. Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, et al. (2009) Variants in MTNR1B influence fasting glucose levels. Nat Genet 41: 77-81.
26. Saxena R, Hivert MF, Langenberg C, Tanaka T, Pankow JS, et al. (2010) Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet 42: 142-148.
27. Soranzo N, Sanna S, Wheeler E, Gieger C, Radke D, et al. (2010) Common variants at 10 genomic loci influence hemoglobin A(C) levels via glycemic and nonglycemic pathways. Diabetes 59: 3229-3239.
28. Strawbridge RJ, Dupuis J, Prokopenko I, Barker A, Ahlqvist E, et al. (2011) Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes 60: 2624-2634.
29. Heitzeneder S, Seidel M, Forster-Waldl E, Heitger A, (2012) Mannan-binding lectin deficiency- Good news, bad news, doesn't matter? Clin Immunol 143: 22-38.
30. Noreen M, Shah MA, Mall SM, Choudhary S, Hussain T, et al. (2012) TLR4 polymorphisms and disease susceptibility. Inflamm Res 61: 177-188.
31. Muller YL, Hanson RL, Bian L, Mack J, Shi X, et al. (2010) Functional variants in MBL2 are associated with type 2 diabetes and pre-diabetes traits in Pima Indians and the old order Amish. Diabetes 59: 2080-2085.
32. Arora P, Garcia-Bailo B, Dastani Z, Brenner D, Villegas A, et al. (2011) Genetic polymorphisms of innate immunity-related inflammatory pathways and their association with factors related to type 2 diabetes. BMC Med Genet 12: 95.
33. Haagsman HP, Hogenkamp A, van Eijk M, Veldhuizen EJ, (2008) Surfactant collectins and innate immunity. Neonatology 93: 288-294.
34. Moreno-Navarrete JM, Fernandez-Real JM, (2011) Antimicrobial-sensing proteins in obesity and type 2 diabetes: the buffering efficiency hypothesis. Diabetes Care 34Suppl 2: S335-341.
35. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772.
36. Wright JR, (2004) Host defense functions of pulmonary surfactant. Biol Neonate 85: 326-332.
37. Fairbrother WG, Yeh RF, Sharp PA, Burge CB, (2002) Predictive identification of exonic splicing enhancers in human genes. Science 297: 1007-1013.
38. Lahti M, Lofgren J, Marttila R, Renko M, Klaavuniemi T, et al. (2002) Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection. Pediatr Res 51: 696-699.
39. Floros J, Lin HM, Garcia A, Salazar MA, Guo X, et al. (2000) Surfactant protein genetic marker alleles identify a subgroup of tuberculosis in a Mexican population. J Infect Dis 182: 1473-1478.
40. Lund MB, Kongerud J, Boe J, Nome O, Abrahamsen AF, et al. (1996) Cardiopulmonary sequelae after treatment for Hodgkin's disease: increased risk in females? Ann Oncol 7: 257-264.
41. Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J, (1997) Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J 10: 822-827.
42. Trotter A, Hilgendorff A, Kipp M, Beyer C, Kueppers E, et al. (2009) Gender-related effects of prenatal administration of estrogen and progesterone receptor antagonists on VEGF and surfactant-proteins and on alveolarisation in the developing piglet lung. Early Hum Dev 85: 353-359.
43. Provost PR, Boucher E, Tremblay Y, (2009) Apolipoprotein A-I, A-II, C-II, and H expression in the developing lung and sex difference in surfactant lipids. J Endocrinol 200: 321-330.